NCT04754139Completed
A Promotion and Implementation Project of HIV Pre-Exposure Prophylaxis Among High Risk Population
Source: ClinicalTrials.gov · Last updated 3 Oct 2024
Brief summary (registry, in English)
This study aims to use a social media mini-application-enabled intervention to successfully promote the initiation and persistence of pre-exposure prophylaxis (PrEP) among at-risk people 18 years and above (including men who have sex with men (MSM), transgender women, sex workers, and other key populations) in Wuhan and Guangzhou, China.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 1200 (actual)
- First submitted
- 11 Feb 2021
- Start date
- 24 Sept 2021
- Primary completion date
- 30 Sept 2024
- Lead sponsor
- University of Chicago
- Diseases
- HIV
- NCT number
- NCT04754139
What you commit to
- Study type: Interventional
- Participants enrolled: 1200
- From 24 Sept 2021 to the primary completion date, 30 Sept 2024
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Chronic hepatitis B (HBV) infection
- HIV infection
- Indication for HIV post-exposure prophylaxis
- Signs and symptoms consistent with acute HIV infection
Age
- Under the age range of 18
Other
- History renal dysfunction
Who the study is looking for
- Age 18+
- Engaged in at-risk sex. At risk sex is defined as sex with \>1 partner in the past 90 days, inconsistent condom use with vaginal or anal sex, ongoing sexual relationship with an HIV-positive partner, participation in commercial sex work, or any bacterial STI diagnosed or reported in the past 6 months.
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Guangzhou Eighth People's Hospital Coordinator of this site? Confirm its status | Guangzhou | China | Unknown status |
| Zhongnan Hospital of Wuhan University Coordinator of this site? Confirm its status | Wuhan | China | Unknown status |
Related publications
- The safety and tolerability of oral TDF/FTC as pre-exposure prophylaxis among men who have sex with men in China: a prospective cohort study.BMC Infect Dis · 2026 · PMID 42168904
This page is information, not medical advice. Discuss any trial with your doctor.